On July 11, 2023 Neurocrine Biosciences, Inc. (Nasdaq: NBIX) reported that it has scheduled its second quarter 2023 financial results conference call and webcast for 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) on August 1, 2023 (Press release, Neurocrine Biosciences, JUL 11, 2023, View Source [SID1234633169]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
The schedule for the press release and conference call / webcast is as follows:
• Q2 2023 Press Release:
August 1, 2023 at 4:00 a.m. PT / 7:00 a.m. ET
• Q2 2023 Conference Call:
August 1, 2023 at 5:00 a.m. PT / 8:00 a.m. ET
• Domestic Dial-In Number:
800-895-3361
• International Dial-In Number:
785-424-1062
• Conference ID:
NBIX
The webcast can also be accessed on Neurocrine Biosciences’ website under Investors at www.neurocrine.com. A replay of the webcast will be available on the website approximately one hour after the conclusion of the event and will be archived for approximately one month.